A study using Swedish patient data found anti-obesity drugs were linked with fewer hospitalizations related to alcohol use, ...
Adial Pharmaceuticals expands its IP with a U.S. patent for targeted AUD treatment using AD04, supporting its personalized ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...
A new study out of Boston shows the promise of an alcohol-mimicking drug for patients with a debilitating neurological voice ...